Summary
- HCA Healthcare shows strong technical indicators with 100% buy signals, a 15.65% gain since 7/24, and 20 new highs in the last month.
- The company operates a wide range of healthcare facilities and services, with a market cap of $103 billion and a P/E ratio of 19.15.
- Analysts provide strong support with 15 strong buy ratings and price targets ranging from $316 to $445, highlighting consistent patient volume growth.
- Despite MorningStar's below-average rating, HCA's long-term strategies have yielded positive results, making it a compelling option for momentum-oriented investors.